Barclays Sticks to Their Buy Rating for Mettler-Toledo (MTD)

In a report released today, Luke Sergott from Barclays maintained a Buy rating on Mettler-Toledo, with a price target of $1,550.00.

Claim 50% Off TipRanks Premium and Invest with Confidence

• Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
• Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential

Sergott covers the Healthcare sector, focusing on stocks such as Illumina, Exact Sciences, and Mettler-Toledo. According to TipRanks, Sergott has an average return of -2.1% and a 42.02% success rate on recommended stocks.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Mettler-Toledo with a $1,511.90 average price target.

Based on Mettler-Toledo’s latest earnings release for the quarter ending September 30, the company reported a quarterly revenue of $1.03 billion and a net profit of $217.49 million. In comparison, last year the company earned a revenue of $954.54 million and had a net profit of $211.52 million

Based on the recent corporate insider activity of 49 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of MTD in relation to earlier this year. Last month, Shawn Vadala, the CFO of MTD sold 2,025.00 shares for a total of $2,999,300.00.